ANI Pharma Launches Kionex Suspension For Oral Or Rectal Use

RTTNews | 218 days ago
ANI Pharma Launches Kionex Suspension For Oral Or Rectal Use

(RTTNews) - Biopharmaceutical company ANI Pharmaceuticals, Inc. (ANIP) announced Monday the launch of Kionex (Sodium Polystyrene Sulfonate Suspension USP) for Oral or Rectal use.

Kionex Suspension is the only commercially available therapeutically equivalent to the reference listed drug (RLD) SPS Suspension for Oral or Rectal use.

The U.S. annual sales for Sodium Polystyrene Sulfonate Oral / Rectal Suspension total approximately $30.3 million, based on March 2024 moving annual total (MAT) IQVIA data.

read more
Canadian Dollar Rises Against Majors

Canadian Dollar Rises Against Majors

The Canadian dollar strengthened against other major currencies in the Asian session on Wednesday. The Canadian dollar rose to more than a 4-1/2-month high of 0.8943 against the Australian dollar, from yesterday's closing value of 0.8955.
RTTNews | 5h 16min ago
Japan Leading Index Data Due On Wednesday

Japan Leading Index Data Due On Wednesday

Japan will on Wednesday see October results for its leading and coincident indexes, highlighting a light day for Asia-Pacific economic activity.
RTTNews | 11h 22min ago
TSX Ends Shortened Session On Firm Note

TSX Ends Shortened Session On Firm Note

The Canadian market ended the shortened trading session on Tuesday modestly higher thanks to gains in energy and technology sectors. The volume of business remained rather thin as investors refrained from making significant moves ahead of Christmas and Boxing Day holidays.
RTTNews | 15h 39min ago